期刊文献+

PRPS1基因在儿童急性白血病中的表达及其临床意义 被引量:5

PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance
下载PDF
导出
摘要 目的:研究PRPS1基因在儿童急性白血病(AL)中的表达及其与该病临床特征的相关性。方法:采用实时荧光定量PCR和Western blot的方法分别检测176例儿童AL(初诊126例,完全缓解50例)中PRPS1 mRNA和蛋白的表达水平,分析其表达水平与临床特征的相关性。以21例非恶性血液病患儿骨髓作为对照。结果:①在BALL组中,PRPS1在初诊组表达水平显著高于对照组,同时高于完全缓解组(P均<0.0001);在T-ALL及AML组中,仅在初诊组与完全缓解组中有差异(P均<0.0001);②在B-ALL样本中,PRPS1表达水平随危险度升高而增加(P<0.01);在T-ALL中各危险度分层组间则无明显差异(P>0.05);在AML样本中,仅低危组与高危组差异具有统计学意义(P<0.05);③PRPS1高表达与B-ALL患儿的高WBC计数及MRD阳性相关(P=0.020,P=0.026);4PRPS1与之前证实的复发相关基因NT5C2表达水平呈正相关(P<0.05)。结论:PRPS1是儿童B-ALL预后不良相关危险因素,有望成为判断预后,指导个性化化疗的指标。 Objective: To investigate the correlation between the expression level of PRPS1 and the clinical characteristics in children with acute leukemia (AL). Methods: Real-time quantitative RT-PCR and Western blot were used to detect the level of PRPS1 rnRNA and protein expression in bone marrow samples from 176 patients diagnosed as AL ( 126 cases were newly diagnosed and 50 cases in complete remission), and its relevance with clinical indicators was statistically analyzed. The bone marrow samples from 21 children with non-malignant hematological disease were used as controls. Results : ( 1 ) In B-ALL group, the level of PRPS1 mRNA in newly diagnosed patients were significantly higher than that in control and than that in complete remission patients ( both P 〈 0. 0001 ). In T-ALL and AML group, differences was only observed between newly diagnosed patients and complete remission patients ( both P 〈 0. 0001 ) ; (2)In B-ALL group, the expression level of PRPS1 increase with along risk enhancement (P 〈 0.01 ), while no significant difference was observed in T-ALL ( P 〉 0.05 ). In AML patients, expression difference was shown between low risk group and high risk group (P 〈 0. 05 ) ; (3)High PRPS1 mRNA expression level were associated with high WBC counts and MRD positive in B-ALL patients ( P = 0. 020, P = 0. 026, respectively) ; ( 4 ) Expression of NT5C2, an essential gene for relapse and drug resistance, was found to be positively correlated with PRPS1 expression in AL samples(P 〈 0. 05 ). Conclusion: High expression of PRPS1 is relevant factor of unfavourable prognosis in B-ALL children, which suggest PRPS! may be a new indicator for prognosis of pediatric B-ALL and an index to guide individualized chemotherapy.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2017年第2期311-317,共7页 Journal of Experimental Hematology
基金 重庆医科大学附属儿童医院转化医学研究项目(7000030)
关键词 PRPS1基因 儿童急性白血病 B淋巴细胞急性白血病 危险因素 PRPS1 gene children acute leukemia B cell acute lymphoblastic leukemia risk factor
  • 相关文献

参考文献2

二级参考文献18

  • 1顾龙君.儿童急性髓细胞白血病诊疗建议[J].中华儿科杂志,2006,44(11):877-878. 被引量:159
  • 2Pan B F,Biochem Pharmacol,1990年,40卷,1063页
  • 3Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratifica- tion, and therapy of pediatric acute leukemias: an update [J]. Clin Oneol, 2011, 29(5):551-565.
  • 4Filoni DN, Pesi R, Careddu MG, et al. Initial studies to define the physiologic role of oN-II [J]. Nucleosides Nucleotides Nucleic Acids, 2011, 30( 12):1155-1160.
  • 5Tozzi MG, Camici M, Pesi R, et al. Nucleoside phosphotransfer- ase activity of human colon carcinoma cytosolic 5'-nueleotidase [J]. Arch Biochem Biophys, 1991, 291 (2):212-217.
  • 6Pieters R, Huismans DR, Loonen AH, et al. Relation of 5'- nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia[ J]. Leuk Res, 1992, 16(9):873-880.
  • 7Hubeek I, Stain RW, Peters GJ, et al. The human equilibrativenucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia[J]. Br J Cancer, 2005, 93 (12):1388-1394.
  • 8Galmarini CM, Thomas X, Calvo F, et al. Potential mechanisms of resistance to cytarabine in AML patients[J]. Leuk Res, 2002, 26(7): 621-629.
  • 9Galmarini CM, Thomas X, Graham K, et al. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine[J]. Br J Haematol, 2003, 122( 1 ):53-60.
  • 10Suzuki K, Sugawara T, Oyake T, et al. Clinical significance of high-Kin 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome [J]. Leuk Res, 2007, 31 (10):1343- 1349.

共引文献10

同被引文献25

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部